CIPLA vs DRREDDY vs ZYDUSLIFE vs LAURUSLABS: which stock is better?
Laurus Labs Limited (LAURUSLABS) has the highest StockLens rating in this group at 7.3/10 (Good).
| Metric | CIPLA | DRREDDY | ZYDUSLIFE | LAURUSLABS |
|---|---|---|---|---|
| Overall rating | 5.0/10 (Average) | 4.7/10 (Average) | 6.9/10 (Good) | 7.3/10 (Good) |
| Long-term view | Neutral (watchlist) | Neutral (watchlist) | Good for long-term | Good for long-term |
| Trade bias | Long bias | Strong long | Strong long | Strong long |
| Share price | ₹1,418.50 | ₹1,400.90 | ₹1,202.90 | ₹2,306.00 |
| Market cap | ₹1,14,599 Cr | ₹1,16,788 Cr | ₹1,19,990 Cr | ₹1,24,596 Cr |
| P/E | 39.6 | 41.7 | 28.7 | 93.1 |
| Return on equity | 8.3% | 7.3% | 14.7% | 24.0% |
| Debt / equity | 0.02 | 0.19 | 0.46 | 0.42 |
| Revenue growth (YoY) | -1.1% | -1.5% | +29.2% | +33.4% |
| 1-year return | -6.6% | +13.9% | +26.4% | +133.1% |
Educational information, not investment advice. Data from Yahoo Finance and NSE Indices; prices may be delayed.